Business Description
Vera Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US92337R1014
Share Class Description:
VERA: Class ADescription
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.58 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.6 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45 | |||||
3-Year EPS without NRI Growth Rate | 43.6 | |||||
3-Year FCF Growth Rate | 36.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | -4.89 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 69.91 | |||||
9-Day RSI | 59.83 | |||||
14-Day RSI | 54.65 | |||||
6-1 Month Momentum % | 39.19 | |||||
12-1 Month Momentum % | 123.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 28.63 | |||||
Quick Ratio | 28.63 | |||||
Cash Ratio | 27.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.5 | |||||
Shareholder Yield % | -15.21 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -53.75 | |||||
ROA % | -40.12 | |||||
ROIC % | -1561.55 | |||||
ROC (Joel Greenblatt) % | -2516.71 | |||||
ROCE % | -42.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.65 | |||||
Price-to-Tangible-Book | 5.65 | |||||
EV-to-EBIT | -18.68 | |||||
EV-to-Forward-EBIT | -20.09 | |||||
EV-to-EBITDA | -18.68 | |||||
EV-to-FCF | -16.76 | |||||
Price-to-Net-Current-Asset-Value | 5.7 | |||||
Price-to-Net-Cash | 5.92 | |||||
Earnings Yield (Greenblatt) % | -5.35 | |||||
FCF Yield % | -4.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VERA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vera Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.05 | ||
Beta | 1.04 | ||
Volatility % | 149.14 | ||
14-Day RSI | 54.65 | ||
14-Day ATR ($) | 1.858246 | ||
20-Day SMA ($) | 35.73 | ||
12-1 Month Momentum % | 123.12 | ||
52-Week Range ($) | 9.24 - 50.78 | ||
Shares Outstanding (Mil) | 54.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vera Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vera Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Vera Therapeutics Inc Frequently Asked Questions
What is Vera Therapeutics Inc(VERA)'s stock price today?
The current price of VERA is $36.66. The 52 week high of VERA is $50.78 and 52 week low is $9.24.
When is next earnings date of Vera Therapeutics Inc(VERA)?
The next earnings date of Vera Therapeutics Inc(VERA) is 2024-08-09 Est..
Does Vera Therapeutics Inc(VERA) pay dividends? If so, how much?
Vera Therapeutics Inc(VERA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |